Related Experiment Video
Updated: Jun 17, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles
P V Asharani1, Ng Xinyi, M Prakash Hande
1Department of Chemistry, Faculty of Science, 3 Science Drive 3, National University of Singapore, Singapore. phsmph@nus.edu.sg
Aim:
Platinum-based therapeutic agents are widely used in medicine. Thus, a thorough understanding of their mechanism of action in cells is warranted. This study investigates the uptake and bioactivity (e.g., cytotoxicity, genotoxicity and protein expression) of platinum nanoparticles (Pt-NPs, approximately 5-8 nm in size) in human cells.
Materials & Methods:
Pt-NPs capped with polyvinyl alcohol were synthesized, characterized and incubated with human cells. Uptake and the biological properties were evaluated through metabolic activity, genome integrity, cell cycle and protein expression.
Results:
Pt-NPs entered the cells through diffusion, and localized inside the cytoplasm. Exposure to the Pt-NP increased DNA damage, accumulation of cells at the S-phase of the cell cycle and apoptosis. A significant number of cells recovered from the stress and formed colonies. Protein-expression levels uncovered upregulation of p53, phosphorylated p53, p21 and downregulation of proliferating cell nuclear antigen following Pt-NP treatment. Pro-caspase 3 and poly-ADP ribose polymerase and cyclin B levels were not altered in both the cell types after Pt-NP exposure.
Conclusion:
The results suggest p53 activation in Pt-NP-treated cells due to genotoxic stress, with subsequent activation of p21 leading to a proliferating cell nuclear antigen-mediated growth arrest and apoptosis. This study recommends development of Pt-NP-based anticancer agents by appropriate surface modifications to augment its innate anticancer activity.
Insights
Platinum nanoparticles (Pt-NPs) enter human cells, causing DNA damage and apoptosis via p53 activation. Some cells recover, suggesting potential for Pt-NP-based anticancer therapies.
Area of Science:
- Nanomedicine
- Cellular Biology
- Toxicology
Background:
- Platinum-based drugs are vital therapeutics.
- Understanding platinum nanoparticle (Pt-NP) cellular mechanisms is crucial.
- Pt-NPs (5-8 nm) are investigated for their biological effects.
Purpose of the Study:
- Investigate Pt-NP uptake in human cells.
- Evaluate Pt-NP bioactivity, including cytotoxicity and genotoxicity.
- Analyze Pt-NP effects on protein expression.
Main Methods:
- Synthesized and characterized polyvinyl alcohol-capped Pt-NPs.
- Incubated Pt-NPs with human cells.
- Assessed metabolic activity, genome integrity, cell cycle, and protein expression.
Main Results:
- Pt-NPs diffused into the cytoplasm.
- Pt-NP exposure induced DNA damage, S-phase arrest, and apoptosis.
- p53 pathway activation (p53, p-p53, p21) was observed, with PCNA downregulation.
Conclusions:
- Genotoxic stress from Pt-NPs activates the p53/p21 pathway, causing growth arrest and apoptosis.
- Cellular recovery and colony formation indicate resilience.
- Pt-NPs show promise for developing novel anticancer agents with surface modifications.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules

